VA106483 Dose Response in Females

Status:
Completed

Trial end date:
2010-11-01

Target enrollment:

Participant gender:

The purpose of this study is to describe the pharmacokinetics and pharmacodynamics of VA106483 in female subjects.

Phase 1

Vantia Ltd